Cargando…

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention

Current diagnostic tests for Mycobacterium tuberculosis (MTB) infection have low prognostic specificity for identifying individuals who will develop tuberculosis (TB) disease, making mass preventive therapy strategies targeting all MTB-infected individuals impractical in high-burden TB countries. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiore-Gartland, Andrew, Carpp, Lindsay N., Naidoo, Kogieleum, Thompson, Ethan, Zak, Daniel E., Self, Steve, Churchyard, Gavin, Walzl, Gerhard, Penn-Nicholson, Adam, Scriba, Thomas J., Hatherill, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Churchill Livingstone 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884308/ https://www.ncbi.nlm.nih.gov/pubmed/29559122 http://dx.doi.org/10.1016/j.tube.2017.11.009

Ejemplares similares

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Clinical predictors of pulmonary tuberculosis among South African adults with HIV
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
por: Scriba, Thomas J, et al.
Publicado: (2021)

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
por: Mulenga, Humphrey, et al.
Publicado: (2021)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
por: Sumner, Tom, et al.
Publicado: (2019)

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Plasma Type I IFN Protein Concentrations in Human Tuberculosis
por: Llibre, Alba, et al.
Publicado: (2019)

Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol
por: Mulenga, Humphrey, et al.
Publicado: (2019)

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
por: Penn-Nicholson, Adam, et al.
Publicado: (2020)

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
por: Baguma, Richard, et al.
Publicado: (2021)

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
por: Scriba, Thomas J., et al.
Publicado: (2017)

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis
por: Mulenga, Humphrey, et al.
Publicado: (2020)

Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
por: Petruccioli, Elisa, et al.
Publicado: (2016)

Advances in tuberculosis control during the past decade
por: Naidoo, Kogieleum, et al.
Publicado: (2023)

HIV-Associated Tuberculosis
por: Naidoo, Kogieleum, et al.
Publicado: (2011)

The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study
por: Sumner, Tom, et al.
Publicado: (2021)

Host blood RNA signatures predict the outcome of tuberculosis treatment
por: Thompson, Ethan G., et al.
Publicado: (2017)

A prospective blood RNA signature for tuberculosis disease risk
por: Zak, Daniel E., et al.
Publicado: (2016)

Blood transcriptional signatures for tuberculosis testing
por: Mendelsohn, Simon C, et al.
Publicado: (2020)

Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis
por: Bhagwan, Smita, et al.
Publicado: (2011)

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis
por: Nandlal, Louansha, et al.
Publicado: (2022)

Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases
por: Kotze, Leigh Ann, et al.
Publicado: (2022)

Effect of Inflammatory Cytokines/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa
por: Rambaran, Santhuri, et al.
Publicado: (2021)

Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection
por: Duffy, Darragh, et al.
Publicado: (2020)

Improving survival with tuberculosis & HIV treatment integration: A mini-review
por: Naidoo, Kogieleum, et al.
Publicado: (2019)

TB epidemiology: where are the young women? Know your tuberculosis epidemic, know your response
por: Perumal, Rubeshan, et al.
Publicado: (2018)

Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
por: Perumal, Rubeshan, et al.
Publicado: (2014)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
por: Baguma, Richard, et al.
Publicado: (2017)

End-point definition and trial design to advance tuberculosis vaccine development
por: Garcia-Basteiro, Alberto L., et al.
Publicado: (2022)

Multidimensional analysis of immune responses identified biomarkers of recent Mycobacterium tuberculosis infection
por: Lloyd, Tessa, et al.
Publicado: (2021)

Systematic review of diagnostic and prognostic host blood transcriptomic signatures of tuberculosis disease in people living with HIV
por: Mendelsohn, Simon C, et al.
Publicado: (2023)

Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
por: Duffy, Fergal J., et al.
Publicado: (2019)

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts
por: Duffy, Fergal J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uk4s0cb1j952koorh6urmjivjm